Literature DB >> 12663645

The effects of the levonorgestrel intrauterine system (Mirena coil) on endometrial morphology.

V Phillips1, C T Graham, S Manek, W G McCluggage.   

Abstract

AIMS: The Mirena coil is a levonorgestrel releasing intrauterine device that is in widespread use. This study aims to document the endometrial morphology associated with this device.
METHODS: Endometrial specimens from 75 women with the Mirena coil were reviewed and the histological features detailed.
RESULTS: Morphological features found in most of the endometria were decidualisation of stroma (72 of 75 cases), atrophy of endometrial glands (65 of 75 cases), a surface papillary pattern (38 of 75 cases), and a stromal inflammatory cell infiltrate (59 of 75 cases). Additional common histological features were the presence of foci of stromal myxoid change (29 of 75 cases) and stromal haemosiderin pigment (24 of 75 cases). Reactive atypia of surface glands, glandular metaplastic changes, stromal necrosis, and stromal calcifications were found in small numbers of cases.
CONCLUSION: The endometrial features are characteristic and relatively constant and are in keeping with the effects of both a progestogenic compound and a mechanical device. Pathologists should be aware of these histological features because the Mirena coil is in widespread use.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12663645      PMCID: PMC1769918          DOI: 10.1136/jcp.56.4.305

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  16 in total

1.  Pregnancy associated endometriosis with pronounced stromal myxoid change.

Authors:  W G McCluggage; S J Kirk
Journal:  J Clin Pathol       Date:  2000-03       Impact factor: 3.411

2.  Endometrial morphology during long-term use of levonorgestrel-releasing intrauterine devices.

Authors:  S G Silverberg; M Haukkamaa; H Arko; C G Nilsson; T Luukkainen
Journal:  Int J Gynecol Pathol       Date:  1986       Impact factor: 2.762

3.  Comparative quantitation of menstrual blood loss with a d-norgestrel-releasing iud and a Nova-T-copper device.

Authors:  C G Nilsson
Journal:  Contraception       Date:  1977-04       Impact factor: 3.375

4.  Treatment of menorrhagia with the levonorgestrel intrauterine system versus endometrial resection.

Authors:  O Istre; B Trolle
Journal:  Fertil Steril       Date:  2001-08       Impact factor: 7.329

5.  Primary treatment of endometrial cancer with progestagen alone.

Authors:  J G Thornton; L A Brown; M Wells; J S Scott
Journal:  Lancet       Date:  1985-07-27       Impact factor: 79.321

6.  Fertility-preserving treatment in young patients with endometrial adenocarcinoma.

Authors:  Chen-Bin Wang; Chin-Jung Wang; Huei-Jean Huang; Swei Hsueh; Hung-Hsueh Chou; Yung-Kuei Soong; Chyong-Huey Lai
Journal:  Cancer       Date:  2002-04-15       Impact factor: 6.860

Review 7.  Reversal by medical treatment of endometrial hyperplasia caused by estrogen replacement therapy.

Authors:  P R Figueroa-Casas; B Ettinger; E Delgado; A Javkin; C Vieder
Journal:  Menopause       Date:  2001 Nov-Dec       Impact factor: 2.953

8.  The levonorgestrel intrauterine system in menopausal hormone replacement therapy: five-year experience.

Authors:  E Suvanto-Luukkonen; A Kauppila
Journal:  Fertil Steril       Date:  1999-07       Impact factor: 7.329

9.  Intrauterine progesterone treatment of early endometrial cancer.

Authors:  Fredrick J Montz; Robert E Bristow; Alessandro Bovicelli; Rafael Tomacruz; Robert J Kurman
Journal:  Am J Obstet Gynecol       Date:  2002-04       Impact factor: 8.661

Review 10.  Levonorgestrel intra-uterine system for menorrhagia.

Authors: 
Journal:  Drug Ther Bull       Date:  2001-11
View more
  10 in total

Review 1.  My approach to the interpretation of endometrial biopsies and curettings.

Authors:  W G McCluggage
Journal:  J Clin Pathol       Date:  2006-08       Impact factor: 3.411

2.  Progesterone-based intrauterine device use is associated with a thinner apical layer of the human ectocervical epithelium and a lower ZO-1 mRNA expression.

Authors:  Annelie Tjernlund; Ann M Carias; Sonia Andersson; Susanna Gustafsson-Sanchez; Maria Röhl; Pernilla Petersson; Andrea Introini; Thomas J Hope; Kristina Broliden
Journal:  Biol Reprod       Date:  2015-01-14       Impact factor: 4.285

3.  [Myxoid alteration of a cervical stroma cells. Mimicry of a tumor].

Authors:  J Placke; D Schmidt
Journal:  Pathologe       Date:  2013-07       Impact factor: 1.011

4.  The effectiveness of levonorgestrel releasing intrauterine system in the treatment of endometrial hyperplasia in Korean women.

Authors:  Seo Yeong Lee; Mi Kyoung Kim; Hyun Park; Bo Sung Yoon; Seok Ju Seong; Jin Hee Kang; Hye Sun Jun; Chong Taik Park
Journal:  J Gynecol Oncol       Date:  2010-06-30       Impact factor: 4.401

5.  Association of baseline bleeding pattern on amenorrhea with levonorgestrel intrauterine system use.

Authors:  Manuela Mejia; Colleen McNicholas; Tessa Madden; Jeffrey F Peipert
Journal:  Contraception       Date:  2016-06-27       Impact factor: 3.375

6.  Development of endometrial cancer after long-term usage of the levonorgestrel-releasing intrauterine system.

Authors:  Alexander Steshenko; Leila Hanna; Damian Collins
Journal:  BMJ Case Rep       Date:  2021-05-13

7.  LNG-IUS treatment of non-atypical endometrial hyperplasia in perimenopausal women: a randomized controlled trial.

Authors:  Hatem Abu Hashim; Abdelhady Zayed; Essam Ghayaty; Mohamed El Rakhawy
Journal:  J Gynecol Oncol       Date:  2013-04-05       Impact factor: 4.401

8.  Markers of human endometrial hypoxia can be detected in vivo and ex vivo during physiological menstruation.

Authors:  J J Reavey; C Walker; M Nicol; A A Murray; H O D Critchley; L E Kershaw; J A Maybin
Journal:  Hum Reprod       Date:  2021-03-18       Impact factor: 6.918

9.  LNG-IUS vs. medical treatments for women with heavy menstrual bleeding: A systematic review and meta-analysis.

Authors:  Sijing Chen; Jianhong Liu; Shiyi Peng; Ying Zheng
Journal:  Front Med (Lausanne)       Date:  2022-08-25

10.  Involvement of cyclin B1 in progesterone-mediated cell growth inhibition, G2/M cell cycle arrest, and apoptosis in human endometrial cell.

Authors:  Li Tang; Yu Zhang; Hong Pan; Qiong Luo; Xiao-Ming Zhu; Min-Yue Dong; Peter Ck Leung; Jian-Zhong Sheng; He-Feng Huang
Journal:  Reprod Biol Endocrinol       Date:  2009-12-07       Impact factor: 5.211

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.